138 related articles for article (PubMed ID: 6287348)
1. Basic and clinical electrophysiology of demyelinating diseases.
Ritchie JM; Waxman SG; Waksman BH
Neurology; 1981 Oct; 31(10):1308-10. PubMed ID: 6287348
[No Abstract] [Full Text] [Related]
2. Pathophysiology of demyelination.
Rasminsky M
Ann N Y Acad Sci; 1984; 436():68-85. PubMed ID: 6099708
[No Abstract] [Full Text] [Related]
3. Membranes, myelin, and the pathophysiology of multiple sclerosis.
Waxman SG
N Engl J Med; 1982 Jun; 306(25):1529-33. PubMed ID: 7043271
[No Abstract] [Full Text] [Related]
4. Electrophysiology of demyelinating diseases: future directions and questions.
Waxman SG; Ritchie JM
Adv Neurol; 1981; 31():511-13. PubMed ID: 6275675
[No Abstract] [Full Text] [Related]
5. Demyelination in spinal cord injury and multiple sclerosis: what can we do to enhance functional recovery?
Waxman SG
J Neurotrauma; 1992 Mar; 9 Suppl 1():S105-17. PubMed ID: 1588601
[TBL] [Abstract][Full Text] [Related]
6. Impulse conduction in multiple sclerosis: a theoretical basis for modification by temperature and pharmacological agents.
Schauf CL; Davis FA
J Neurol Neurosurg Psychiatry; 1974 Feb; 37(2):152-61. PubMed ID: 4362242
[TBL] [Abstract][Full Text] [Related]
7. Neurophysiology in multiple sclerosis.
Eisen A
Neurol Clin; 1983 Aug; 1(3):615-29. PubMed ID: 6095010
[TBL] [Abstract][Full Text] [Related]
8. Conduction properties of central demyelinated and remyelinated axons, and their relation to symptom production in demyelinating disorders.
Smith KJ
Eye (Lond); 1994; 8 ( Pt 2)():224-37. PubMed ID: 7958027
[TBL] [Abstract][Full Text] [Related]
9. Hyperexcitability of pathologically myelinated axons and positive symptoms in multiple sclerosis.
Rasminsky M
Adv Neurol; 1981; 31():289-97. PubMed ID: 6275667
[No Abstract] [Full Text] [Related]
10. The pathophysiology of demyelination and the ionic basis of nerve conduction in multiple sclerosis: an overview.
Boyden KM
J Neurosci Nurs; 2000 Feb; 32(1):49-53, 60. PubMed ID: 10955274
[TBL] [Abstract][Full Text] [Related]
11. The morphological basis for alterations in nerve conduction in peripheral neuropathy.
Thomas PK
Proc R Soc Med; 1971 Mar; 64(3):295-8. PubMed ID: 4101503
[No Abstract] [Full Text] [Related]
12. Approaches to the development of pharmacological interventions in multiple sclerosis.
Davis FA; Schauf CL
Adv Neurol; 1981; 31():505-10. PubMed ID: 6275674
[No Abstract] [Full Text] [Related]
13. Central remyelination restores secure conduction.
Smith KJ; Blakemore WF; McDonald WI
Nature; 1979 Aug; 280(5721):395-6. PubMed ID: 460414
[No Abstract] [Full Text] [Related]
14. Remyelination in human CNS lesions.
Hommes OR
Prog Brain Res; 1980; 53():39-63. PubMed ID: 7005954
[No Abstract] [Full Text] [Related]
15. Overcoming conduction failure in demyelinated nerve fibres by prolonging action potentials.
Bostock H; Sherratt RM; Sears TA
Nature; 1978 Jul; 274(5669):385-7. PubMed ID: 209331
[No Abstract] [Full Text] [Related]
16. In response to "Correlations of nerve conduction measures in axonal and demyelinating polyneuropathies".
Caliandro P; Stålberg E; Padua L
Clin Neurophysiol; 2008 Jul; 119(7):1694-5. PubMed ID: 18467169
[No Abstract] [Full Text] [Related]
17. Effects of 4-aminopyridine on demyelinated axons, synapses and muscle tension.
Smith KJ; Felts PA; John GR
Brain; 2000 Jan; 123 ( Pt 1)():171-84. PubMed ID: 10611131
[TBL] [Abstract][Full Text] [Related]
18. NEUROMUSCULAR TRANSMISSION IN A SPIDER AND THE EFFECT OF CALCIUM.
RATHMAYER W
Comp Biochem Physiol; 1965 Apr; 14():673-87. PubMed ID: 14327579
[No Abstract] [Full Text] [Related]
19. [The structural and functional heterogeneity of the axon membrane of mammalian myelinated nerve fibers and saltatory conduction].
Xu ML
Sheng Li Ke Xue Jin Zhan; 1982 Jul; 13(3):266-9. PubMed ID: 6294825
[No Abstract] [Full Text] [Related]
20. [New views on the pathophysiology of disseminated sclerosis].
Cendrowski W
Neurol Neurochir Pol; 1972; 6(5):817-21. PubMed ID: 4655986
[No Abstract] [Full Text] [Related]
[Next] [New Search]
